NO992944L - Virkestoffbµrer for avgivelse av apomorfin i munnhulen - Google Patents

Virkestoffbµrer for avgivelse av apomorfin i munnhulen

Info

Publication number
NO992944L
NO992944L NO992944A NO992944A NO992944L NO 992944 L NO992944 L NO 992944L NO 992944 A NO992944 A NO 992944A NO 992944 A NO992944 A NO 992944A NO 992944 L NO992944 L NO 992944L
Authority
NO
Norway
Prior art keywords
apomorphine
oral cavity
delivery
active ingredient
oblate
Prior art date
Application number
NO992944A
Other languages
English (en)
Norwegian (no)
Other versions
NO992944D0 (no
Inventor
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO992944D0 publication Critical patent/NO992944D0/no
Publication of NO992944L publication Critical patent/NO992944L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO992944A 1996-12-16 1999-06-16 Virkestoffbµrer for avgivelse av apomorfin i munnhulen NO992944L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19652268A DE19652268C2 (de) 1996-12-16 1996-12-16 Arzneizubereitung für die Freisetzung von Apomorphin in der Mundhöhle
PCT/EP1997/006529 WO1998026763A1 (fr) 1996-12-16 1997-11-21 Excipient pour liberer de l'apomorphine dans la cavite buccale

Publications (2)

Publication Number Publication Date
NO992944D0 NO992944D0 (no) 1999-06-16
NO992944L true NO992944L (no) 1999-06-16

Family

ID=7814859

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992944A NO992944L (no) 1996-12-16 1999-06-16 Virkestoffbµrer for avgivelse av apomorfin i munnhulen

Country Status (8)

Country Link
EP (1) EP0959875A1 (fr)
JP (1) JP2001506612A (fr)
KR (1) KR20000057627A (fr)
AU (1) AU746373B2 (fr)
CA (1) CA2274893A1 (fr)
DE (1) DE19652268C2 (fr)
NO (1) NO992944L (fr)
WO (1) WO1998026763A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US6596298B2 (en) 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
US6291471B1 (en) 1998-12-17 2001-09-18 Abb Holdings, Inc. Use of apomorphine for the treatment of organic erectile dysfunction in males
US6540978B1 (en) 1998-12-23 2003-04-01 Mount Sinai School Of Medicine Of New York University Inhibitors of the bitter taste response
US7314716B2 (en) 1999-11-19 2008-01-01 Mount Sinai School Of Medicine Gustducin γ subunit materials and methods
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
DE60233217D1 (de) 2001-05-01 2009-09-17 Corium Internat Inc Hydrogel-zusammensetzungen
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
DE10252726B4 (de) * 2002-11-13 2008-05-08 Lts Lohmann Therapie-Systeme Ag Mehrschichtiges transmucosales therapeutisches System
EP1583431A1 (fr) * 2002-11-14 2005-10-12 Givaudan SA Film comestible contenant un acide nutritif
KR100945741B1 (ko) * 2003-01-16 2010-03-05 부광약품 주식회사 염산아포모르핀을 함유하는 구강스프레이 제제
CA2554649C (fr) 2004-01-30 2015-10-27 Corium International, Inc. Film a dissolution rapide pour la delivrance d'agent actif
US20050281757A1 (en) * 2004-06-17 2005-12-22 Sayed Ibrahim Oral care film
CA2751884C (fr) 2009-01-14 2018-09-25 Corium International, Inc. Administration transdermique de tamsulosine
WO2010144817A1 (fr) * 2009-06-12 2010-12-16 Adagio Pharmaceuticals Ltd. Apomorphine sublinguale
KR101946774B1 (ko) 2010-12-16 2019-02-11 선오비온 파마슈티컬스 인코포레이티드 설하 필름
US10806703B2 (en) * 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
WO2015070156A1 (fr) * 2013-11-11 2015-05-14 Impax Laboratories, Inc. Formulations à désintégration rapide et leurs méthodes d'utilisation
JP7211706B2 (ja) * 2015-04-21 2023-01-24 サノヴィオン ファーマシュティカルズ インコーポレーテッド 口腔粘膜へのアポモルフィンの投与によるパーキンソン病の治療方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3972995A (en) * 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
DE2746414A1 (de) * 1977-10-15 1979-04-26 Gerlach Eduard Chem Fab Mittel zum dosieren von stoffen und verfahren zu seiner herstellung
DK0758895T3 (da) * 1994-04-22 2000-06-13 Pentech Pharmaceuticals Inc Sublinguale dosisformer indeholdende apomorphin til anvendelse ved behandling af erektil dysfunktion
FR2732896B1 (fr) * 1995-04-11 1997-06-13 Prographarm Lab Forme pharmaceutique transdermique pour l'administration percutanee de l'apomorphine

Also Published As

Publication number Publication date
JP2001506612A (ja) 2001-05-22
AU5654798A (en) 1998-07-15
NO992944D0 (no) 1999-06-16
AU746373B2 (en) 2002-04-18
DE19652268C2 (de) 2000-06-29
KR20000057627A (ko) 2000-09-25
CA2274893A1 (fr) 1998-06-25
EP0959875A1 (fr) 1999-12-01
DE19652268A1 (de) 1998-06-18
WO1998026763A1 (fr) 1998-06-25

Similar Documents

Publication Publication Date Title
NO992944L (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
IT8719064A0 (it) Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive.
GR910100283A (el) Στερεά από του στόματος χορηγουμένη φαρμακευτική μορφή δοσιμετρήσεως προγραμματισμένου ρυ?μού απελευ?ερώσεως.
NO992907L (no) Flat legemiddeltilberedning for applikasjon og frigiving av buprenorfin eller et annet farmakologisk sammenlignbart stoff i munnhulen og fremgangsmÕte for dens fremstilling
DE69100991D1 (de) Pharmazeutische formulierungen.
AU1227899A (en) Osmotic medicament releasing system
AU3345197A (en) Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
IE894048L (en) New therapeutically active compound and a process for its¹preparation
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
AU2506388A (en) Azelastine-containing medicaments for application in the nose and/or at the eye
AR026968A1 (es) Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral
CA2136404A1 (fr) Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale
IE894049L (en) Therapeutically active substituted benzimidazole and process¹for its preparation
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
WO2000048445A3 (fr) Composition pharmaceutique contenant de la desoxypeganine utilisee pour le traitement de la dependance a la nicotine
AU3278800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
AR012996A1 (es) Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador.
ATE169818T1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
DE60007074D1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application